JBCHEPHARMNSEJB Chemicals & Pharmaceuticals Limited· PharmaceuticalsMediumNeutral
Announced Wed, 14 May · 20:25 IST

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about re-appointment of Statutory Auditor

Management Changes View source PDF

JBCHEPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

JB Chemicals & Pharmaceuticals has re-appointed M/s. Deloitte Haskins & Sells LLP, Chartered Accountants, as its Statutory Auditor. The re-appointment was approved by the Board of Directors on May 14, 2025, and the firm will hold office until the conclusion of the company's 54th Annual General Meeting. The re-appointment is subject to approval from members at the upcoming general meeting. Deloitte Haskins & Sells LLP, a Big 4 accounting firm, has offices across major Indian cities including Mumbai, Gurugram, Bangalore, and Chennai.

Likely market impact

This is a routine governance update indicating continuity with a well-known Big 4 auditor, which generally signals stable audit oversight. No material impact on shareholders or stock price is expected from this re-appointment.